We transiently expressed ID2 in a panel of prostate cancer cell lines; Western blot analysis showed decreased expression of AR and PSA in LNCAP cells, while the expression of NE markers such as CHGA, ENO2, and SYP was elevated in both LNCAP and PC3 cells (Figure 3A). Here, ID2 is linked to prostate carcinoma.